Vladimir Ratushny

MD, PhD

2026 Sessions

Innovation Theater (non-accredited) - Adjuvant Treatment with LIBTAYO for Patients with Cutaneous Squamous Cell Carcinoma (CSCC) at High Risk of Recurrence After Surgery and Radiation

  • Presenter
    • Vladimir Ratushny
Back to top